Literature DB >> 25553128

Metastatic Melanoma in the Femur - Case Report with Review of Literature: a Pathologist's Point of View.

Mariana Costache1, Alexandra Stoica2, Andreea Contolenco2, Diana Costache3, Catalin Cirstoiu4, Olga Simionescu5, Simion George2.   

Abstract

ABSTRACT: The aim of this case report was to evaluate the histopathological characteristics on a patient with metastases in the femur from malignant melanoma. A review from the literature is also mentioned.We present a case of metastatic malignant melanoma in the femur with known primary site in a 44-year-old-female. Diagnosis was confirmed by histopathology.Malignant melanoma is a cancer that may metastasise in the skeleton. However most of bone metastases are found in the axial skeleton and they rarely involve the femur, as in our case. Only a few case reports are published in the literature. Clinicians must be aware of the varied clinical manifestations of disseminated malignant melanoma.The diagnosis for metastatic malignant melanoma is confirmed due to pathological examination. Immunohistochemical study is useful in diagnosis, mainly when malignant melanoma is poorly differen-tiated.

Entities:  

Keywords:  femur; malignant melanoma; metastases

Year:  2014        PMID: 25553128      PMCID: PMC4268294     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  14 in total

1.  Cerebral metastases from malignant melanoma.

Authors:  G Stevens; I Firth; A Coates
Journal:  Radiother Oncol       Date:  1992-03       Impact factor: 6.280

2.  Analysis of dose fractionation in the palliation of metastases from malignant melanoma.

Authors:  J B Konefal; B Emami; M V Pilepich
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

Review 3.  Malignant melanoma: Mayo Clinic experience.

Authors:  F H Sim; T E Nelson; D J Pritchard
Journal:  Mayo Clin Proc       Date:  1997-06       Impact factor: 7.616

4.  Metastases from malignant melanoma to the axial skeleton: a CT study of frequency and appearance.

Authors:  R M Patten; W P Shuman; S Teefey
Journal:  AJR Am J Roentgenol       Date:  1990-07       Impact factor: 3.959

5.  Prognostic correlations and response to treatment in advanced metastatic malignant melanoma.

Authors:  L H Einhorn; M A Burgess; C Vallejos; G P Bodey; J Gutterman; G Mavligit; E M Hersh; J K Luce; E Frei; E J Freireich; J A Gottlieb
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

6.  Metastatic pattern of malignant melanoma. A study of 216 autopsy cases.

Authors:  J K Patel; M S Didolkar; J W Pickren; R H Moore
Journal:  Am J Surg       Date:  1978-06       Impact factor: 2.565

Review 7.  Malignant melanoma: prevention, early detection, and treatment in the 21st century.

Authors:  D S Rigel; J A Carucci
Journal:  CA Cancer J Clin       Date:  2000 Jul-Aug       Impact factor: 508.702

8.  T1 hyperintense vertebral column melanoma metastases.

Authors:  D S McMenamin; S L Stuckey; G J Potgieter
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

9.  Prognostic factors in 1,521 melanoma patients with distant metastases.

Authors:  A Barth; L A Wanek; D L Morton
Journal:  J Am Coll Surg       Date:  1995-09       Impact factor: 6.113

10.  Metastatic malignant melanoma in bone marrow with occult primary site--a case report with review of literature.

Authors:  Deepali Jain; Tejindar Singh; Naresh Kumar; Mradul K Daga
Journal:  Diagn Pathol       Date:  2007-10-02       Impact factor: 2.644

View more
  2 in total

1.  Extra-Axial Skeletal Metastasis of Malignant Melanoma: Case Report and Literature Review.

Authors:  Keerthi Gullapalli; Priyal Agarwal; Osama Mosalem; Venumadhavi Gogineni; Richa Tikaria
Journal:  Cureus       Date:  2022-02-11

2.  High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6.

Authors:  Guang-Liang Chen; Yubin Luo; Daniel Eriksson; Xianyi Meng; Cheng Qian; Tobias Bäuerle; Xiao-Xiang Chen; Georg Schett; Aline Bozec
Journal:  Oncotarget       Date:  2016-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.